These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4552442)

  • 41. The use of luciferase-reporter phage for antibiotic-susceptibility testing of mycobacteria.
    Riska PF; Jacobs WR
    Methods Mol Biol; 1998; 101():431-55. PubMed ID: 9921495
    [No Abstract]   [Full Text] [Related]  

  • 42. Pulmonary nontuberculous mycobacterial infections in immunocompetent patients.
    Cook JL
    Clin Lab Sci; 1999; 12(5):302-8. PubMed ID: 10623329
    [No Abstract]   [Full Text] [Related]  

  • 43. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.
    Sanguinetti M; Ardito F; Fiscarelli E; La Sorda M; D'Argenio P; Ricciotti G; Fadda G
    J Clin Microbiol; 2001 Feb; 39(2):816-9. PubMed ID: 11158161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chemo-antibiotic-resistance in vitro of "atypical" mycobacteria and Mycobacterium tuberculosis].
    Caroli G; Spaziante G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):535-46. PubMed ID: 4967922
    [No Abstract]   [Full Text] [Related]  

  • 47. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility.
    Uslan DZ; Kowalski TJ; Wengenack NL; Virk A; Wilson JW
    Arch Dermatol; 2006 Oct; 142(10):1287-92. PubMed ID: 17043183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The thuggacins, novel antibacterial macrolides from Sorangium cellulosum acting against selected Gram-positive bacteria.
    Irschik H; Reichenbach H; Höfle G; Jansen R
    J Antibiot (Tokyo); 2007 Dec; 60(12):733-8. PubMed ID: 18276996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The talking Mycobacterium abscessus blues.
    Griffith DE
    Clin Infect Dis; 2011 Mar; 52(5):572-4. PubMed ID: 21292660
    [No Abstract]   [Full Text] [Related]  

  • 50. Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
    Kobaisy M; Abramowski Z; Lermer L; Saxena G; Hancock RE; Towers GH; Doxsee D; Stokes RW
    J Nat Prod; 1997 Nov; 60(11):1210-3. PubMed ID: 9392889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycobacterium thermoresistibile infection following knee-replacement surgery.
    LaBombardi VJ; Shastry L; Tischler H
    J Clin Microbiol; 2005 Oct; 43(10):5393-4. PubMed ID: 16208028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of disease caused by nontuberculous mycobacteria.
    Bass JB; Hawkins EL
    Arch Intern Med; 1983 Jul; 143(7):1439-41. PubMed ID: 6870414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pulmonary infection by Mycobacterium malmoense in a patient with AIDS].
    López R; Redondo MP; Ruiz D; Geijo P
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):47-8. PubMed ID: 9147514
    [No Abstract]   [Full Text] [Related]  

  • 55. The diagnosis of two cases of cutaneous ulcer caused by infection with Mycobacterium haemophilum: direct identification in a clinical sample by polymerase chain reaction-restriction endonuclease analysis.
    Da Mata O; Pérez Alfonzo R; Natera I; Sucre Rdel C; Bello T; de Waard JH
    Int J Dermatol; 2008 Aug; 47(8):820-3. PubMed ID: 18717862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usefulness of the Etest for studying tigecycline susceptibility of non-pigmented rapidly growing mycobacteria.
    Martín-de-Hijas NZ; Fernández-Roblas R; Fernandez-Martínez AI; Gadea I; Esteban J
    Int J Antimicrob Agents; 2008 Oct; 32(4):366-7. PubMed ID: 18572391
    [No Abstract]   [Full Text] [Related]  

  • 57. [Isoxyl and T283 in the treatment of photochromogenic infections in mice].
    Burjanová B; Dornetzhuber V
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):123-5. PubMed ID: 5632189
    [No Abstract]   [Full Text] [Related]  

  • 58. [Quality control of culture media for mycobacterium drug sensitivity tests].
    Kekkaku; 2003 Aug; 78(8):563-8. PubMed ID: 14582504
    [No Abstract]   [Full Text] [Related]  

  • 59. Nontuberculous mycobacterium infection in a burn ICU patient.
    Boyer JM; Blatz PJ; Akers KS; Okulicz JF; Chung KK; Renz EM; Hospenthal DR; Murray CK
    Burns; 2010 Nov; 36(7):e136-9. PubMed ID: 20594758
    [No Abstract]   [Full Text] [Related]  

  • 60. [Sensitivity of mycobacteria to antibacillary agents].
    Tison F
    J Sci Med Lille; 1972 Nov; 90(11):401-3. PubMed ID: 4650211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.